Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Wittebole

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
European Journal of Drug Metabolism and Pharmacokinetics|September 24, 2020
Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose OptimizationPauline Thémans, Leila Belkhir, Nicolas Dauby, et al.
Annals of Intensive Care|December 10, 2023
Inhaled drug delivery: a randomized study in intubated patients with healthy lungsJonathan Dugernier, Déborah Le Pennec, Guillaume Maerckx, et al.
Brain Sciences|April 30, 2021
The Prognostic Value of Brain Dysfunction in Critically Ill Patients with and without Sepsis: A <i>Post Hoc</i> Analysis of the ICON AuditIlaria A Crippa, Fabio S Taccone, Xavier Wittebole, et al.
Critical Care Medicine|February 6, 2004
Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trialSteven Opal, Pierre-Francois Laterre, Edward Abraham, et al.
Journal of Critical Care|December 11, 2025
Survival after ICU discharge is shaped more by chronic disease than admission severityAlice Blet, Anouk Walter-Petrich, Ményssa Chérifa, et al.
Kidney International|August 14, 2020
SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubuleAlexis Werion, Leila Belkhir, Marie Perrot, et al.
American Journal of Respiratory and Critical Care Medicine|February 8, 2011
Recombinant tissue factor pathway inhibitor in severe community-acquired pneumonia: a randomized trialRichard G Wunderink, Pierre-François Laterre, Bruno Francois, et al.
Ebiomedicine|February 26, 2022
Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patientsVirginie Montiel, Irina Lobysheva, Ludovic Gérard, et al.
Thorax|September 3, 2014
Myeloid-related protein-8/14 facilitates bacterial growth during pneumococcal pneumoniaAhmed Achouiti, Thomas Vogl, Henrik Endeman, et al.
JAMA|March 25, 2020
Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017Jean-Louis Vincent, Yasser Sakr, Mervyn Singer, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
European Journal of Drug Metabolism and Pharmacokinetics|September 24, 2020
Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose OptimizationPauline Thémans, Leila Belkhir, Nicolas Dauby, et al.
Annals of Intensive Care|December 10, 2023
Inhaled drug delivery: a randomized study in intubated patients with healthy lungsJonathan Dugernier, Déborah Le Pennec, Guillaume Maerckx, et al.
Brain Sciences|April 30, 2021
The Prognostic Value of Brain Dysfunction in Critically Ill Patients with and without Sepsis: A <i>Post Hoc</i> Analysis of the ICON AuditIlaria A Crippa, Fabio S Taccone, Xavier Wittebole, et al.
Critical Care Medicine|February 6, 2004
Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trialSteven Opal, Pierre-Francois Laterre, Edward Abraham, et al.
Journal of Critical Care|December 11, 2025
Survival after ICU discharge is shaped more by chronic disease than admission severityAlice Blet, Anouk Walter-Petrich, Ményssa Chérifa, et al.
Kidney International|August 14, 2020
SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubuleAlexis Werion, Leila Belkhir, Marie Perrot, et al.
American Journal of Respiratory and Critical Care Medicine|February 8, 2011
Recombinant tissue factor pathway inhibitor in severe community-acquired pneumonia: a randomized trialRichard G Wunderink, Pierre-François Laterre, Bruno Francois, et al.
Ebiomedicine|February 26, 2022
Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patientsVirginie Montiel, Irina Lobysheva, Ludovic Gérard, et al.
Thorax|September 3, 2014
Myeloid-related protein-8/14 facilitates bacterial growth during pneumococcal pneumoniaAhmed Achouiti, Thomas Vogl, Henrik Endeman, et al.
JAMA|March 25, 2020
Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017Jean-Louis Vincent, Yasser Sakr, Mervyn Singer, et al.
Pageof 12